The Impact of Worsening Heart Failure in the United States.
dc.contributor.author | Cooper, Lauren B | |
dc.contributor.author | DeVore, Adam D | |
dc.contributor.author | Michael Felker, G | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2015-12-03T17:31:11Z | |
dc.date.issued | 2015-10 | |
dc.description.abstract | In-hospital worsening heart failure represents a clinical scenario wherein a patient hospitalized for acute heart failure experiences a worsening of their condition, requiring escalation of therapy. Worsening heart failure is associated with worse in-hospital and postdischarge outcomes. Worsening heart failure is increasingly being used as an endpoint or combined endpoint in clinical trials, as it is unique to episodes of acute heart failure and captures an important event during the inpatient course. While prediction models have been developed to identify worsening heart failure, there are no known FDA-approved medications associated with decreased worsening heart failure. Continued study is warranted. | |
dc.identifier | ||
dc.identifier | S1551-7136(15)00057-4 | |
dc.identifier.issn | 1551-7136 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Elsevier BV | |
dc.relation.ispartof | Heart Fail Clin | |
dc.relation.isversionof | 10.1016/j.hfc.2015.07.004 | |
dc.subject | Clinical trials | |
dc.subject | Medications | |
dc.subject | Outcomes | |
dc.subject | Worsening heart failure | |
dc.subject | Acute Disease | |
dc.subject | Clinical Trials as Topic | |
dc.subject | Heart Failure | |
dc.subject | Hospitalization | |
dc.subject | Humans | |
dc.subject | Incidence | |
dc.subject | Registries | |
dc.subject | United States | |
dc.title | The Impact of Worsening Heart Failure in the United States. | |
dc.type | Journal article | |
duke.contributor.orcid | DeVore, Adam D|0000-0002-4679-2221 | |
pubs.author-url | ||
pubs.begin-page | 603 | |
pubs.end-page | 614 | |
pubs.issue | 4 | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Medicine, Cardiology | |
pubs.organisational-group | School of Medicine | |
pubs.publication-status | Published | |
pubs.volume | 11 |
Files
Original bundle
- Name:
- The Impact of Worsening HF in the US.pdf
- Size:
- 275.71 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version